US OptionsDetailed Quotes
GLUE241220C10000
- 0.59
- +0.09+18.00%
15min DelayClose Nov 26 16:00 ET
0.59High0.35Low
0.35Open0.50Pre Close504 Volume295 Open Interest10.00Strike Price22.74KTurnover95.56%IV23.14%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.59Extrinsic Value100Contract SizeAmericanOptions Type0.3138Delta0.1691Gamma22.93Leverage Ratio-0.0160Theta0.0015Rho7.20Eff Leverage0.0078Vega
Monte Rosa Therapeutics Stock Discussion
Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(6.6%),Versant Ventures VI GP, L.P.(6.6%), etc.
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Versant Venture Capital VI, L.P.
No comment yet